Epalrestat
Epalrestaat CAS nr .: 82159-09-9
Epalrestat is a non-competitive inhibitor of aldose reductase, which reversibly inhibits the conversion of glucose into sorbitol aldose reductase in polyol metabolism associated with the pathogenesis of diabetic complications, and can significantly improve The patient's symptoms and neurological dysfunction improve their motor nerve conduction velocity and autonomic function.
Epalrestati kasutatakse diabeediga seotud perifeerse neuropaatia (tuimus, valu), vibratsiooniparesteesia ja südame kõrvalekallete ennetamiseks, leevendamiseks ja raviks. SPETSIFIKATSIOON
Epalrestat is a non-competitive inhibitor of aldose reductase, which reversibly inhibits the conversion of glucose into sorbitol aldose reductase in polyol metabolism associated with the pathogenesis of diabetic complications, and can significantly improve The patient's symptoms and neurological dysfunction improve their motor nerve conduction velocity and autonomic function.
Epalrestati kasutatakse diabeediga seotud perifeerse neuropaatia (tuimus, valu), vibratsiooniparesteesia ja südame kõrvalekallete ennetamiseks, leevendamiseks ja raviks. SPETSIFIKATSIOON
| P rodukti nimi | Epalrestat |
| CAS | 82159-09-9 |
| MF: | C15H13NO3S2 |
| MW: | 319,4 |
Kirjutage oma sõnum siia ja saatke see meile
